Abstract

P1.13-36 Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines
M Puglisi ... U Banerji
Lung cancer (Amsterdam, Netherlands) | VOL. 85
M Puglisi, et. al.M Puglisi ... U Banerji
01 Jun 2014
Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway
Jian-Cai Tang ... Zhen Jiang
Life sciences. Pt. 1: Physiology and pharmacology | VOL. 204
Jian-Cai Tang, et. al.Jian-Cai Tang ... Zhen Jiang
05 May 2018
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.
Lecia V Sequist ...
The Oncologist | VOL. 24
Lecia V Sequist, et. al.Lecia V Sequist ...
12 Apr 2019
Epidermal growth factor tyrosine kinase inhibitor therapy inferior to second-line chemotherapy in EGFR wild-type non-small cell lung cancer patients: results of French nationwide observational study.
Aaron Lisberg ... Edward B Garon
Translational lung cancer research | VOL. 6
Aaron Lisberg, et. al.Aaron Lisberg ... Edward B Garon
01 Dec 2017
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer – IASLC Early Detection and Screening Committee Expert Group Recommendations
Rudolf M Huber ... Rudolf Huber
Journal of Thoracic Oncology | VOL. -
Rudolf M Huber, et. al.Rudolf M Huber ... Rudolf Huber
02 Aug 2024
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
David Kozono ... Mary W Redman
Journal of Thoracic Oncology | VOL. -
David Kozono, et. al.David Kozono ... Mary W Redman
01 Aug 2024
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy
Peter S.N Van Rossum ... José S.A Belderbos
Journal of Thoracic Oncology | VOL. -
Peter S.N Van Rossum, et. al.Peter S.N Van Rossum ... José S.A Belderbos
25 Jul 2024
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
View more papers